AbbreviationsATadipose tissueBUNurea nitrogenCHOLcholesterolCNIcalcineurin inhibitorGLUglucoseGWASgenome‐wide association studiesHbA1Cglycosylated hemoglobin A1CHCChepatocellular carcinomaHLAhuman leukocyte antigenHRMhigh‐resolution meltingICDinternational classification of diseasesIL28Binterleukin 28BIP‐10interferon‐inducible protein 10IRSinsulin receptor substrateISGsIFN‐stimulated genesMCP‐1monocyte chemoattractant protein‐1MFImedian fluorescence intensityMIP‐1bmacrophage inflammatory protein‐1 betaPTDMposttransplantation diabetes mellitusSA‐PEstreptavidin‐phycoerythrinSNPssingle nucleotide polymorphismsSOCSsuppressor of cytokine signalingSTAT4signal transducer and activator of transcription 4TGtriglycerideINTRODUCTIONPosttransplantation diabetes mellitus (PTDM) is a frequent complication in patients treated with the immunosuppressive calcineurin inhibitor tacrolimus (Tac; FK506). Approximately 30%‐40% of liver transplant recipients have sustained diabetes beyond 6 months after transplant. The true prevalence of insulin resistance in patients after liver transplantation is unknown but presumed to be even greater. It is important to find biological markers that can predict the risk of PTDM; this could also provide new ideas for individualized therapies. Recent studies have identified single nucleotide polymorphisms (SNPs) associated with PTDM risk among Tac‐treated patients. It has been suggested that genotyping diabetes‐related polymorphisms could be a possible method of predicting a patient's risk for developing PTDM, and this information could be a valuable asset in the selection of appropriate immunosuppressive regimens.Posttransplantation diabetes mellitus is characterized by a combination of insulin resistance and insulin hyposecretion in liver transplant recipients. It has been reported that there is a particularly high prevalence of insulin resistance associated with viral
Journal of Clinical Laboratory Analysis – Wiley
Published: Jan 1, 2018
Keywords: ; ; ; ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera